HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Brawley, J. V. Articles by Concannon, P. Search for Related Content PubMed PubMed Citation Articles by Brawley, J. V. Articles by Concannon, P.

Complementarity-Determining Region 1 Sequence Requirements Drive Limited V Usage in Response to Influenza Hemagglutinin 307–319 Peptide¹

Molecular Genetics Program, Virginia Mason Research Center, Seattle, WA 98101; and Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195

We have developed a T cell activation-based system that allows for the selection of TCRs with defined peptide/MHC specificities from libraries in which complementarity-determining region (CDR) sequences have been randomized by in vitro mutagenesis. Using this system, we have explored the sequence requirements for CDR1 and CDR2 of the TCR -chain in a human T cell response characterized by restricted V and V usage. Libraries of T cells expressing receptors built on the framework of a TCR specific for the influenza virus peptide hemagglutinin 307–319 presented by HLA-DR4, but with random sequences inserted at CDR1 or CDR2, were selected for response to the same peptide/MHC ligand. A wide variety of CDR2 sequences were found to be permissive for recognition. Indeed, >25% of T cell clones chosen at random displayed a significant response. In contrast, a similar challenge of a randomized CDR1 library yielded only the parental sequence, and then only after multiple rounds of selection. T cell clones cross-reactive on closely related HLA alleles (subtypes of DR4) could be isolated from randomized libraries, but not clones restricted by more distantly related alleles such as HLA-DR1. These results indicate that, in the context of this T cell response, the structural requirements for recognition at CDR1 are significantly more restricted than at CDR2. This system for mutation and selection of TCRs in vitro may be of use in engineering T cells with defined specificities for therapeutic applications.